Claritev Corporation (CTEV)

Market Closed

1 Sep, 20:00

NYSE

39. 35

-0.48

-1.2051%

After Hours

45. 00

+5.65 +14.3583%

671.51M Market Cap

- P/E Ratio

- Div Yield

134,831 Volume

- Eps

$ 39.83

Previous Close

Investors:

Add Transaction

Day Range

38.83 40.82

Year Range

11.5 74.07

Want to track CTEV and more in your Portfolio? 🎯

Get Started For Free

Claritev Q2 Earnings Call Highlights

Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, prompting the healthcare technology company to raise its full-year revenue, adjusted EBITDA and free-cash-flow outlook.

Marketbeat | 3 weeks ago

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago

Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates

Claritev Corporation (CTEV) came out with a quarterly loss of $3.49 per share versus the Zacks Consensus Estimate of a loss of $4.1. This compares to earnings of $0.32 per share a year ago.

Zacks | 3 weeks ago

Claritev Q1 Earnings Call Highlights

Claritev NYSE: CTEV reported first-quarter 2026 revenue and adjusted EBITDA ahead of internal expectations, while management said sales momentum and new-market expansion support its full-year outlook.

Marketbeat | 3 months ago

Claritev Corporation (CTEV) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 months ago

Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates

Claritev Corporation (CTEV) came out with a quarterly loss of $4.41 per share versus the Zacks Consensus Estimate of a loss of $3.81. This compares to a loss of $3.43 per share a year ago.

Zacks | 3 months ago